Short answer
Core Scientific, Inc./tx (CORZ) filed its Q3 2025 10-Q quarterly report on Oct 24, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $81M (down 14.9% year over year) with net income of −$147M.
Q3 2025 key financials · XBRL
- Revenue
- $81M
- −14.9% YoY · +3.1% QoQ
- Net income
- −$147M
- +67.8% YoY · +84.3% QoQ
- Operating margin
- -70.8%
- Gross margin
- 4.8%
- EPS (diluted)
- −$1.27
- −51.2% YoY · +13.0% QoQ
Source: XBRL data from the Core Scientific, Inc./tx (CORZ) Q3 2025 10-Q on SEC EDGAR. USD.
Core Scientific, Inc./tx Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added merger risk: $270M termination fee if Merger Agreement terminated due to Board recommendation change or other specified conditions
- Updated regulatory risk: Merger completion dependent on Nasdaq approval of CoreWeave Class A stock listing and no injunctive legal orders
- Legal risk: Potential costly securities class action and derivative lawsuits challenging the Merger could divert management and delay closing
- Operational risk: Integration risks including loss of key personnel and business disruptions may delay or reduce expected Merger benefits
- Financial risk: Merger consideration of 0.1235 CoreWeave shares subject to market price volatility affecting stockholders’ realized value
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Core Scientific, Inc./tx quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.